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INTRODUCTION
The need to refine our understanding of the immune sys-
tem in order to characterize dermatologic disease pathology 
and guide therapy necessitates a better understanding of the 
immune system. One of the most widely employed char-
acterization techniques is flow cytometry. At its core, flow 
cytometry attempts to profile cellular states at a given point 
in time. Newer technologies extend the fundamental scope 
of flow cytometry; mass cytometry provides much more data 
on the specific state of immune cells, and imaging cytometry 
describes single-cell dynamics in heterogeneous mixtures. In 
this article, we introduce and review these two novel exten-
sions to traditional flow cytometry and provide examples that 
can guide future studies that can benefit from these tech-
niques.
NOVEL TECHNOLOGIES FOR EVALUATION OF 
HETEROGENEOUS CELL POPULATIONS
In cutaneous diseases, the interaction between the immune 
system and native local tissue correlates with various disease 
states, and flow cytometry has played an integral role in the 
study of immunology. This technique allows for cell type char-
acterization within blood or other tissue samples via simul-
taneous identification of multiple cellular markers. In this 
manner, cell populations expressing specific markers can be 
associated with certain disease states. In flow cytometry, anti-
bodies labeled with fluorescent dyes (fluorophores) bind cellu-
lar markers. Antibody-bound cells are then analyzed by a flow 
cytometer that measures each cell’s emitted light as it passes a 
detector. Cells bound to different fluorophores will emit light 
at a spectrum specific to the fluorophore, allowing for identifi-
cation of cell populations of interest (Jahan-Tigh et al., 2012). 
Multiple antibodies with different fluorophores can be 
used in the same preparation of cells. However, the potential 
for emitted spectral overlap (“spillover”) among the various 
fluorophores can result in false-positive readings. Despite soft-
ware-based correction and advances in fluorophore design, 
the spillover effect limits the number of antibody targets 
detectable on a cell. Although up to 20 different antibodies 
can be studied simultaneously on a single sample preparation, 
8- or 9-plex studies are routinely performed in practice (Peters 
and Ansari, 2011).
Mass cytometry (CyTOF, or “time of flight”) and imaging 
cytometry are two novel extensions of the flow cytometry tech-
• Mass cytometry (CyTOF) and imaging cytometry 
 (ImageStream) are technological offshoots of 
 traditional flow cytometry that allow 
 characterization of multiple simultaneous cellular 
 and subcellular parameters.
• Mass cytometry uses rare earth metal isotopes to 
 label cells that are then read by a mass 
 spectrometer, allowing for more than 35 labels on 
 each cell.
• Imaging cytometry (ImageStream) combines 
 high-resolution light and fluorescent microscopy 
 to capture an image for each event passing 
 through the detector.
• During the mass cytometry (CyTOF) process, the  
 cells are destroyed, making subsequent cell 
 sorting and analysis impossible.
• Imaging cytometry (ImageStream) suffers from 
 fluorescent dye “spillover,” which continues to 
 limit its multiplexing capabilities.
• The data analysis for both techniques can be 
 complicated given the highly multiplexed nature 
 of these techniques.
WHAT FLOW CYTOMETRY DOES
LIMITATIONS
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nology that expand on the cellular characterization capable of 
traditional flow methods. The focus of this review will be to 
introduce these techniques and envision potential applications 
in the field of investigative dermatology.
MASS CYTOMETRY
Mass cytometry, also known as CyTOF, is a variation on mass 
spectrometry coupled with flow cytometry. This technol-
ogy employs the resolution capabilities of small-molecule 
mass spectrometry scaled to the single-cell level. As in flow 
cytometry, single-cell mass cytometry allows for the simul-
taneous detection and characterization of multiple internal 
(e.g., phosphoproteins) and external (e.g., polysaccharides) 
markers (Bandura et al., 2009; Bendall et al., 2011). Whereas 
traditional flow requires the use of fluorophores, mass cytom-
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shoot that overcomes the need to put the cells into suspen-
sion before analysis by directly labeling thin slices of fixed 
tissue with metal-conjugated antibodies. Either a laser or an 
ion beam, depending on the technique, then scans the tissue 
and releases the metal labels, which are read by an adjacent 
mass cytometer that is then able to reconstruct a multispectral 
image of the tissue (Giesen et al., 2014; Angelo et al., 2014).
In their study, Newell et al. (2013) employed mass cytom-
etry to characterize T cells from the blood of 17 healthy 
donors and intestinal intraepithelial lymphocytes from nine 
gastric bypass patients. In these experiments, between 16 and 
64 million CD8 T cells from each donor were analyzed for 
their ability to recognize viral epitopes including influenza, 
Epstein–Barr virus, cytomegalovirus, and rotavirus. Each T cell 
was stained with 37 heavy metal–labeled antibodies, creating 
etry uses antibodies conjugated to rare earth transition met-
als, which are not found in biological systems (Ornatsky et 
al., 2006). More than 35 different purified metal isotopes are 
employed as labels and more are in development. In prac-
tice, this allows for multiplex detection of upward of 27 dif-
ferent antigens on a single cell (Bendall et al., 2011).
The initial sample preparation process is similar to that of 
classic flow cytometry. Single-cell suspensions are prepared 
from whole tissue, blood samples, bone marrow aspirates, or 
tissue culture. After incubation with the metal-labeled anti-
bodies, the cells of interest are injected into an argon flow 
chamber designed to accommodate cell suspensions (Figure 
1). The cells are swept up by the argon gas into a special-
ized compartment, where they are exposed to a plasma torch 
reaching temperatures of 10,000 K, similar to that found in the 
atmosphere of the sun. The cells and their metal labels are then 
vaporized, atomized, and ionized. Importantly, the cell is now 
represented by an ion “cloud” and the times of flight (TOFs) 
of the ions from the plasma to a mass spectrometer detector 
are then measured. Lighter particles (i.e., metals) arrive at the 
detector earlier than the heavier particles.
The detector measures the metal content found in this cell 
cloud and can discriminate between the signals of heavier 
metal antibody isotopes and the metals normally found in 
biological systems. The CyTOF platform includes software to 
analyze the TOF and, based on the properties of the ionized 
cell cloud, the software can detect the heavy metal isotope 
composition of each cell that is subjected to the spectrometer. 
The mass spectrometer is able to discriminate between iso-
topes of a heavy metal differing by only the weight of a neu-
tron, allowing for fine resolution without the spillover effect 
seen with fluorophore-labeled antibodies. This spillover effect 
is the term given to the overlap of the emitted spectra of two 
different fluorophores (e.g., a predominantly red fluorophore 
gives off some orange signal, which gives a false positive for 
the presence of the orange fluorophore) and is a major limita-
tion of fluorophore-dependent flow cytometry. Because of the 
lack of spillover, the probe set design for mass cytometry with 
a large number of probes (i.e., greater than 30) is much easier 
than that for traditional fluorescent flow cytometry. Another 
unique aspect of mass cytometry is a recent technological off-
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Figure 1.  Schematic representation of both imaging cytometry (top) 
and mass cytometry (bottom). See text for details. (1) Microscope objective 
array with three different objective magnifications. (2) Argon plasma torch.
Figure 2.  Principal-component analysis of mass cytometry data. (a) This 
group of cytometry fluorescence plots compares CD8+ T cells from the 
intestinal intraepithelial lymphocytes (IELs) that are specific for a rotavirus 
epitope called VP3 to the same VP3-specific T cells from the peripheral blood 
(i.e., they are gated on CD8+). Cells that are positive for both markers (in 
this case, CD103 and integrin-β7) are present in the upper right quadrant, 
whereas those negative for the two markers are present in the bottom left. The 
red outlines in the two upper panels and the blue outlines of the two lower 
panels represent the cells that are CD8+ and specific for VP3 of all the CD8+ 
cells (CD8+ cells are represented by black dots). (b) This graph displays the 
first two principal components (i.e., PC1 and PC2) or the first two groups of 
variables (e.g., cell markers) that best predict the variance in the data. In this 
example, each data point represents a donor’s cell marker expression data 
from either peripheral blood or IEL specific for the VP3 epitope. 
(c) Each row in this clustergram is the expression data for a single donor. 
Only the variables that were calculated to be most important for this set of 
data as derived from the principal-component analysis are listed along the 
X axis (CD69, CD103, etc.). Each square correlates with the cumulative 
expression data from millions of that specific donor’s T cells that were 
vaporized after passing through the plasma torch. A separate calculation 
involving the Euclidian distance between values allows similar samples to be 
clustered together. Reprinted from Newell et al., 2013.
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an incredible amount of data to subsequently analyze. One 
commonly employed method to handle these data is princi-
pal-component analysis, in which multiparametric data (e.g., 
the various cell surface markers labeled by the antibodies) are 
reduced to multiple components (e.g., groups of surface mark-
ers), with each component being composed of the variables 
that best predict the distribution of the data (Figure 2), effec-
tively reducing the dimensionality of the data into more man-
ageable parts.
DISADVANTAGES OF MASS CYTOMETRY
One of the important limitations of this technique is the cel-
lular destruction that occurs once the cells reach the plasma 
torch. This prevents purification of specialized cell popula-
tions. Nonetheless, this multiplex system can potentially be 
used in a workflow that incorporates fluorescence-activated 
cell sorting (FACS), whereby the CyTOF technique identifies 
markers of interest in a tissue sample, and FACS isolates the 
cells of interest in a similar later experiment. Another draw-
back is that it is slower, with throughput speeds of 500–1,000 
cells per second compared to traditional flow cytometry/
FACS that can achieve speeds up to 50,000 cells per second.
IMAGING CYTOMETRY
A second offshoot of traditional flow cytometry combines 
high-throughput cytometry with high-resolution bright-field 
and fluorescent microscopy. The basic architecture of the 
apparatus is similar to that of classic flow cytometry whereby 
the biological solution of interest is labeled with fluorescent 
antibodies and injected into a liquid stream. The flow of the 
liquid causes the cells and/or particles to line up until they 
are struck by an excitatory light source, which causes them 
to fluoresce. The most common imaging cytometry platform, 
ImageStream system (Amnis, Seattle, WA), captures image 
data for each of these events that pass through the detector 
system using one or more microscope objectives (e.g., 20×, 
40×, or 60×). The addition of these microscope objectives to 
the flow cytometry apparatus is the fundamental difference 
between classic flow cytometry and imaging cytometry, as 
illustrated in Figure 1 (top). Once the LED light and the exci-
tation lasers strike each cell, pictures of each cell are taken 
by a high-speed camera apparatus as the cell passes through 
the sensors.
With imaging cytometry, each event (e.g., cell, cell frag-
ment, parasite) has an associated set of pictures, in contrast 
to traditional flow cytometry in which no cell images are cap-
tured. In classic flow cytometry with 400- to 500-nm commer-
cially available systems, these events are usually single cells 
passing through the detector apparatus. However, the new-
est ImageStream model, ImageStreamX Mark II, is capable of 
detecting subcellular particles down to sizes of 20 nm when 
combined with fluorescent data (Headland et al., 2014). This 
increased capture resolution dramatically increases the poten-
tial applications of imaging cytometry to include experiments 
elucidating cell–cell interactions, cell signaling localization, 
colocalization of multiple intracellular targets, apoptosis, 
transfection efficiency, cell–therapeutics interactions, and 
cell–pathogen interactions.
The ability of imaging cytometry to separate cellular popu-
lations and colocalize internal cellular processes is  illustrated 
by van der Aar et al. (2013), who compared the antigen 
presentation capability of dermal dendritic cells to that of 
Langerhans cells. In one experiment, Staphylococcus aureus 
bacteria engineered to express green fluorescent protein were 
incubated with both Langerhans cells and dermal dendritic 
cells. This mixture of cells was then labeled with antibodies 
that bind to the membrane-bound vesicles formed after the 
cells internalize the bacteria. Two markers were chosen: one 
that is found on vesicles early after their formation, appropri-
ately named EEA-1 (early endosomal antigen-1), and a second 
that marks lysosomes, LAMP-1 (lysosomal-associated mem-
brane protein-1). The EEA-1 antibody was conjugated to a blue 
fluorophore, and the LAMP-1 antibody was conjugated to a 
red fluorophore. Using the overlay of the green, blue, and red 
fluorophores, the investigators were able to calculate the pro-
portion of Langerhans cells with S. aureus in endosomes and 
lysosomes compared to dermal dendritic cells (Figure 3). The 
experiment showed that after an equivalent amount of time 
with the bacteria inside the cells, the dermal dendritic cells 
had processed more of the bacteria into lysosomes than had 
the Langerhans cells, demonstrating the superior antigen-pro-
cessing capabilities of dermal dendritic cells.
DISADVANTAGES OF IMAGING CYTOMETRY
Like mass cytometry, this technique is slower than traditional 
flow cytometry and, depending on the microscope objective 
used, can range from 1,200 cells per second with the 60× 
objective to 4,000 cells per second with the 20× objective. 
Because this technology uses fluorescent dyes, it contin-
Figure 3.  Imaging cytometry output. Each image is multispectral (composed 
of separate wavelengths of light), which allows only certain channels to be 
viewed simultaneously. The columns show cell images in gray and display 
two channels of information: one is the bright-field (BF) or traditional light 
microscopic image, which is shown as gray, and the second channel displays 
green information representing the fluorescence collected from the green-
fluorescent protein-producing Staphylococcus aureus. Overlaying the two 
channels shows the location of the bacteria inside each cell. The columns 
with blue images demonstrate the fluorescence of the Alexafluor 405 (AF405) 
dye conjugated to the early endosomes, and the reddish-orange images 
display the fluorescence of the phycoerythrin (PE) dye marking lysosomes. 
Reprinted from van der Aar et al., 2013. DDC, dermal dendritic cell; 
LC, Langerhans cell.
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ues to be subject to signal spillover, which limits the num-
ber of simultaneous targets that can be read on a single cell. 
Newer organic polymer dyes capable of conducting elec-
tricity and which produce a more intense fluorescence with 
less spillover represent an attempt to address this limitation 
(Chattopadhyay et al., 2012).
SUMMARY
The future of flow cytometry is bright, with new fluorescent 
dyes, more metal labels, and an ever-expanding set of appli-
cations under development. These technologies provide deep 
profiling of single cells and small-molecule quantification—
techniques that can advance our understanding of cutaneous 
disease and drive development of novel therapeutics.
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1. Which flow analytical technique uses rare earth 
 metal–labeled antibodies?
A. FACS.
B. Mass cytometry (CyTOF).
C. Principal-component analysis.
D. ImageStream.
2. What is an advantage of the ImageStream technique 
 over traditional flow cytometry?
A. It allows for separation of different cell 
 subpopulations in heterogeneous cell mixtures.
B. It captures high-resolution image data for each 
 event passing through the system.
C. It obtains absolute quantification data for 
 subcellular compartments.
D. It can be used on paraffin-embedded tissue 
 sections.
3. As a dermatologist conducting research, you are 
 interested in separating CD4+ lymphocytes from 
 peripheral blood as quickly as possible. Which 
 technique would be preferred?
A. Phase-contrast microscopy.
B. ImageStream.
C. FACS.
D. Mass spectrometry.
4. One of the advantages of CyTOF-based studies is 
 the following.
A. It allows for high-throughput multiplex analysis 
 of protein expression data in single cells.
B. It allows for high-resolution image data 
 collection of single-cell events.
C. It allows for cells to be sorted after staining and 
 data acquisition.
D. It utilizes high-resolution fluorescence data.
5. What do flow cytometry, CyTOF, and ImageStream 
 have in common?
A. They all employ fluorescence-based techniques.
B. Cells are lysed first and subsequently labeled 
 with antibodies of interest.
C. These techniques utilize inductively coupled 
 plasma.
D. Whole-cell suspensions are first labeled with 
 antibodies of interest.
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